Tracy Martinez
Family · Kerrville, TXNPI 1528568441
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 103 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $704 and has fallen 56.1% since, to $309 in 2025.
Across 103 payments — averaging $18.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$411
- AbbVie$281
- Daiichi Sankyo Inc.$271
- Organon$177
- Lilly USA, LLC$121
- Exact Sciences$73
- plus $591 from 20 others
What the payments were for
- Food & beverage$1,924100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 28 | $411 |
| AbbVie | 16 | $281 |
| Daiichi Sankyo Inc. | 15 | $271 |
| Organon | 2 | $177 |
| Lilly USA, LLC | 7 | $121 |
| Exact Sciences | 4 | $73 |
| Vertex | 3 | $61 |
| Pacira Therapeutics, Inc. | 3 | $58 |
| Kowa Pharmaceuticals America, Inc. | 3 | $58 |
| Amarin Pharma, Inc. | 2 | $45 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $43 |
| Pfizer | 2 | $40 |
| GSK | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 2 | $28 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $27 |
| Novartis | 1 | $22 |
| Eisai Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Biohaven Pharmaceuticals, Inc. | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Merck | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$125
How this compares
$1,924 in reported general payments places this provider in the 80th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $203 |
Paid to pharmacies, not to this prescriber.
Other family in Kerrville
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.